Skip to main content
. 2014 Sep 10;21(8):1220–1238. doi: 10.1089/ars.2013.5639

FIG. 8.

FIG. 8.

A model of ways in which miR-210 may affect the response to radiotherapy, based on currently known target genes. ACVR1B, activin receptor 1B; AIFM3, apoptosis-inducing factor, mitochondrion-associated, 3; ATM, Ataxia telangiectasia mutated; BCL2, B-cell lymphoma 2; BHB1b, mitotic checkpoint serine/threonine-protein kinase BUB1 beta; CASP8AP2, caspase-8-associated protein 2; Cdc25B, cell division cycle 25 homolog B; E2F3, E2F transcription factor 3; Fam83d, family with sequence similarity 83, member D; FGFRL1, fibroblast growth factor receptor-like 1; H2AX, histone H2AX; HOXA1, homeobox A1; MDM2, mouse double minute 2 homolog; MNT, MAX-binding protein; PLK1, polo-like kinase 1; PTPN1, tyrosine-protein phosphatase non-receptor type 1.